Ignite Creation Date:
2024-05-05 @ 9:21 PM
Last Modification Date:
2024-10-26 @ 10:03 AM
Study NCT ID:
NCT00867854
Status:
COMPLETED
Last Update Posted:
2017-02-28
First Post:
2009-03-22
Brief Title:
Treatment De-Intensification and Residual HIV-1 in Youth
Sponsor:
University of North Carolina Chapel Hill
Organization:
University of North Carolina Chapel Hill
Study Overview
Official Title:
Treatment De-Intensification and Residual HIV-1 in Adolescents and Young Adults A Sub-Study of ATN 061 and ATN 071
Status:
COMPLETED
Status Verified Date:
2016-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This laboratory-based sub-study of ATN 061 and ATN 071 will examine the effect of early treatment followed by treatment de-intensification to atazanavirritonavir ATVr monotherapy on steady-state frequencies of replication-competent CD4 T cell Human Immunodeficiency Virus HIV-1 reservoirs or cell-associated infectivity CAI and persistent low-level viremia LLV and their contribution to successful long-term control of HIV-1 replication among HIV-1 infected adolescents and young adults
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None